Sunshine Act ‘Open Payments' reports available for review

Article

The U.S. Centers for Medicare and Medicaid Services (CMS) is on track to begin publicly releasing information on industry-physician financial relationship through its new National Physician Payment Transparency Program: Open Payments website (go.cms.gov/openpayments) on Sept. 30.

Editor's note: The Open Payments system was taken offline on August 3, 2014 to resolve a technical issue. To account for system down time, CMS announced it is extending the time for doctors to review their records to September 8, 2014. The public website will be available on September 30, 2014. The content of this article has been changed to reflect the updated deadline, but the timeline, seen above, is now outdated. 

The U.S. Centers for Medicare and Medicaid Services (CMS) is on track to begin publicly releasing information on industry-physician financial relationship through its new National Physician Payment Transparency Program: Open Payments website on Sept. 30.

Beginning in July, healthcare practitioners have an opportunity to review, and if necessary correct, any information on their financial dealings with industry prior to public release. However, they must act promptly, the CMS emphasizes.

Authorized under the Physician Payments Sunshine Act provisions of the federal Affordable Care Act, the Open Payments initiative will for the first time make financial interaction between industry and healthcare practitioners a matter of public record.

How withdrawal of Windows XP support affects you

The act requires manufacturers of covered pharmaceuticals, medical devices, biologics, and medical supplies that are covered by Medicare, Medicaid, or S-CHIP programs, as well as group purchasing organizations (GPOs), to report detailed information about payments or other “transfers of value” worth more than $10 to physicians and teaching hospitals.

The initial Open Payments reporting period was Aug. 1 to Dec. 31, 2013. Manufacturers and GPOs were to submit reports on financial relationship during that period to the CMS by March 31, 2014.

Reports are compiled in the new Enterprise Identification Management (EIDM) system database. The EIDM can be accessed through the CMS Enterprise Portal, which was introduced in June to provide information or facilitate data exchange for a number of emerging agency programs.

The reports will remain available for review for 45 days following their initial posting on the portal. Practitioners will have 60 days following the initial posting of the report to formally dispute inaccuracies and attempt to resolve them. That means the review period for the initial round of Open Payments reports will end on about Sept. 8 with the dispute resolution period to end about Sept. 15.

 

 

 

 

 

CMS urges practitioners to keep a detailed log of financial interactions with industry in order to have a record against which Open Payments reports from industry can be checked. The agency is offering healthcare practitioners free mobile phone apps that have been designed specifically for this purpose (see box).

Resolving a dispute may involve working with industry representatives to correct data, according to CMS. Should a practitioner and industry representatives be unable to resolve a dispute by the close of the 60-day dispute resolution period, the report will be posted online as “disputed” while the affected parties continue to attempt to resolve discrepancies.

The Open Payments website will be updated at least annually, according to the agency.

Healthcare practitioners must register to use the Enterprise Portal. Portal registration is open now and generally requires just a few minutes. However, access to the portal’s Open Payments section requires a second registration process, which may be more time-consuming, the agency says.

CMS officials urge practitioners to open a basic Enterprise Portal account and become acquainted with the portal as soon as possible. Doing so will help ensure practitioners can begin reviewing Open Payment reports quickly.ODT

 

 

 

 

 

 

 

 

Recent Videos
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
© 2025 MJH Life Sciences

All rights reserved.